A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults
Clinical trial NCT01601600 · COMPLETED
Trial details
- NCT number
- NCT01601600
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.